Physicians' Academy for Cardiovascular Education

SGLT2 inhibition in CKD: Discussing the key questions and evidence

Meeting report with presentation slides and video of a PACE-CME symposium held during ERA-EDTA 2019 in Budapest, Hungary on the role of SGLT2i in kidney disease
SGLT2 inhibition in CKD: Discussing the key questions and evidence

10' Education

Outcomes of SGLT2i in Diabetic Kidney Disease: Is it all diabetes?

10' education - July 4, 2019 - ERA-EDTA 2019 - Rajiv Agarwal, MD
SGLT2 inhibition in CKD: Discussing the key questions and evidence

Presentation Slides

Slides: The clinical landscape of managing patients with CKD: Where are we now and what can we expect?

Slides (presentation) - July 3, 2019 - Will Herrington, MD – Oxford, United Kingdom - CME symposium held during ERA EDTA 2019

Slides: The knowns and unknowns of SGLT2 inhibition in CKD

Slides (presentation) - July 3, 2019 - Paola Fioretto, MD – Padua, Italy - CME symposium held during ERA EDTA 2019

Slides: Outcomes of SGLT2i in Diabetic Kidney Disease: Is it all diabetes?

Slides (presentation) - July 3, 2019 - Rajiv Agarwal, MD - Indianapolis, IN, USA - CME symposium held during ERA EDTA 2019